Henderson v. Hoftiezer

CourtDistrict Court, E.D. Wisconsin
DecidedAugust 20, 2020
Docket2:19-cv-00422
StatusUnknown

This text of Henderson v. Hoftiezer (Henderson v. Hoftiezer) is published on Counsel Stack Legal Research, covering District Court, E.D. Wisconsin primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Henderson v. Hoftiezer, (E.D. Wis. 2020).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF WISCONSIN

JUSTIN HENDERSON,

Plaintiff,

v. Case No. 19-CV-422

SCOTT HOFTIEZER,

Defendant.

DECISION AND ORDER ON DEFENDANT’S MOTION FOR SUMMARY JUDGMENT

Plaintiff Justin Henderson, a former Wisconsin state prisoner who is representing himself, filed this lawsuit under 42 U.S.C. § 1983. He asserts a claim under the Eighth Amendment against defendant Scott Hoftiezer, a doctor who worked at Dodge Correctional Institution (“DCI”). The defendant moved for summary judgment. For the reasons explained below, I will grant the defendant’s motion for summary judgment and dismiss this case. FACTS Parties The facts are taken from the defendant’s proposed findings of fact, the defendant’s declaration in support, and the transcript of Henderson’s deposition. (ECF Nos. 25–27.) Henderson did not respond to the defendant’s facts. For purposes of this decision, I will deem admitted the defendant’s proposed facts that Henderson has not properly contested. See Civil L. R. 56(b)(4); Smith v. Lamz, 321 F.3d 680, 683 (7th Cir. 2003) (“We have consistently held that a failure to respond by the nonmovant as mandated by the local rules results in an admission.”). I will consider the proposed

facts only to the extent they are supported by evidence in the record and will consider arguments in the supporting memoranda only to the extent they properly refer to the proposed facts. See Fed. R. Civ. Pro. 56(c)(1); Civil L. R. 56(b)(1)(C)(i), (b)(2)(B)(i)–(ii), and (b)(6). Henderson entered DCI as an inmate on March 7, 2018, and on May 18, 2018, was transferred to the Jackson Correctional Institution, where he remained until his release on August 6, 2019. (ECF No. 25, ¶ 1.) Dr. Hoftiezer was a physician at DCI

from March 25, 2002, through November 15, 2003, and a Physician Supervisor from November 16, 2003, through November 10, 2019. (Id., ¶ 2.) He also was the Associate Medical Director of the Bureau of Health Services until November 8, 2019. (Id., ¶ 3.) Tuberculosis Background Tuberculosis is a bacterial disease that appears in infected persons in three stages: exposure, latent infection, and active disease. (ECF No. 25, ¶ 4.) Neither an

exposed person nor one with a latent infection will show signs or symptoms of the disease, and neither can spread the disease to others. (Id., ¶¶ 5–6.) Persons with a latent infection can be treated, and often are, to prevent them from developing an active case. (Id., ¶¶ 6–7.) It is not recommended that all persons with a latent infection be treated. (Id., ¶ 8.) Whether to treat depends on weighing the risk of developing an active case with the benefit of treatment. (Id.) 2 If a latent infection is not treated, a person may develop active tuberculosis. (ECF No. 25, ¶ 10.) A person with the active disease shows signs and symptoms of tuberculosis but could have a positive or negative skin or blood test for tuberculosis

or a positive x-ray, biopsy, or other test for tuberculosis. (Id., ¶¶ 9–10.) Only those with active tuberculosis can spread the disease. (Id., ¶ 11.) Tuberculosis at Wisconsin Prisons and DCI On March 1, 2018, the Wisconsin prison system updated its tuberculosis control program to transition away from a skin test for the disease to a blood test known as QuantiFeron Gold (“QuantiFeron”). (ECF No. 25, ¶¶ 12–13.) The traditional skin test results in many false negatives and positives for a latent

infection or active disease. (Id., ¶ 14.) The QuantiFeron test is far more accurate and “is considered the best screening test in this situation,” but it is “not foolproof” and has a false negative rate and “a significant false positive rate.” (Id., ¶¶ 15, 31; ECF No. 27, ¶ 23.) The defendant states that a false negative is more likely if the patient is taking immunosuppressant medication, like Henderson was for his Crohn’s disease. (ECF No. 27, ¶ 23.) Results of the QuantiFeron test must be judged in the

context of the patient’s overall health to determine whether tuberculosis is present. (ECF No. 25, ¶ 15.) If there is a suspected case of tuberculosis in a Wisconsin prison, the inmate is placed into isolation for observation, must wear a surgical mask, and is tested for the active disease. (Id., ¶ 16.) An inmate with latent tuberculosis may be treated with a twelve-week regimen of Isoniazid and Rifapentine. (Id., ¶ 17.)

3 The Wisconsin Department of Corrections has had several cases of latent tuberculosis in the last decade, which the defendant describes as “a common finding both in the community and in the prison system alike.” (ECF No. 25, ¶ 23; ECF

No. 27, ¶ 20.) The defendant reiterates that inmates with latent tuberculosis need not be isolated because they are not infectious, have no symptoms, and cannot spread the disease to others. (ECF No. 25, ¶ 24.) The defendant states that he is aware of only one active case of tuberculosis during his time at DCI, and that was in 2011. (Id., ¶ 18; ECF No. 27, ¶ 17.) That inmate transferred from a jail to DCI, was known to be possibly infectious, and immediately entered isolation to avoid spreading the disease. (ECF No. 25, ¶ 18; ECF No. 27, ¶ 17.) The defendant states that he is not aware of

any active cases of tuberculosis at DCI between March and May 2018, when Henderson was an inmate there. (ECF No. 25, ¶ 19.) Henderson’s Complaint Because Henderson’s complaint is verified, I will consider the contentions in the complaint as I would in an affidavit for purposes of this decision. See Devbrow v. Gallegos, 735 F.3d 584, 587 (7th Cir. 2013); Ford v. Wilson, 90 F.3d 245, 246–47 (7th

Cir. 1996). Henderson states that Dr. Hoftiezer tested him for tuberculosis when he arrived at DCI, and the result was negative. (ECF No. 1 at 2.) At the time Henderson was taking prednisone for his preexisting Crohn’s disease and began taking Humira for Crohn’s in May 2018. (Id.) He states that both medications “deplete[]” his immune system. (Id.) After Henderson was transferred to Jackson Correctional Institution, he 4 received a positive test for latent tuberculosis, which he insists he “did not have upon arriving to prison.” (Id. at 2–3.) Henderson states that tuberculosis has an incubation period of two to twelve weeks, so he “suspect[s] it was DCI” where he became infected.

(Id. at 3.) Henderson states he “feel[s] that” Dr. Hoftiezer and DCI staff failed to contain an active case of tuberculosis at DCI from entering the prison’s general population, and he contracted the disease while housed there. (Id.) Henderson’s Medical Records Henderson’s medical file shows that he received the QuantiFeron test for tuberculosis on March 8, 2018, after he was admitted to DCI. (ECF No. 25, ¶ 25; ECF No. 28-1 at 45.) The defendant reiterates that the QuantiFeron test, while more

accurate than the traditional skin test, has a false negative rate. (ECF No. 25, ¶ 26.) The defendant states that because Henderson lacked symptoms of a tuberculosis infection and had the negative test result, he “was most likely TB free.” (Id., ¶ 27.) Henderson began taking Humira for his Crohn’s disease on May 8, 2018. (Id., ¶ 28; ECF No. 28-1 at 13.) Humira suppresses a person’s immune system and would make them more susceptible to contracting tuberculosis from someone who had an active

case or to activating a latent case of tuberculosis. (ECF No. 25, ¶ 29.) On June 20, 2018, Henderson was seen by a specialist at Gunderson Hospital about his Crohn’s disease. (ECF No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Roy E. Ford v. Curtis Wilson
90 F.3d 245 (Seventh Circuit, 1996)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Viero v. Bufano
925 F. Supp. 1374 (N.D. Illinois, 1996)
Eugene Devbrow v. Steven Gallegos
735 F.3d 584 (Seventh Circuit, 2013)
Miguel Perez v. James Fenoglio
792 F.3d 768 (Seventh Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Henderson v. Hoftiezer, Counsel Stack Legal Research, https://law.counselstack.com/opinion/henderson-v-hoftiezer-wied-2020.